The Curiox C- Free Pluto ALPHA replaces traditional centrifuge-based methods, offering a low-maintenance solution that eliminates bulky hardware. Utilizing a pipette head, it delivers gentle, ...
Curiox Biosystems Signs Master Software License Agreement for Enterprise-Scale Pluto Code Deployment
WOBURN, Mass., April 21, 2026 (GLOBE NEWSWIRE)-- Curiox Biosystems today announced the signing of a Master Software License Agreement with a major global pharmaceutical organization for the deployment ...
Find the Curiox BioSystems financial statements for a comprehensive overview of the company’s financial health. This summary highlights critical numbers from key financial reports, including the ...
Curiox BioSystems (445680) has delivered a 221% change over the past year, with a 52-week range between 29,150 and 149,200. What Is the Average Daily Trading Volume of Curiox BioSystems (445680)? The ...
SEOUL, SOUTH KOREA, Aug. 14, 2023 /PRNewswire/ -- Curiox Biosystems Inc., a global leader in providing innovative and automated sample preparation solutions for accurate and reproducible cell analysis ...
The share price of Curiox Biosystems has surged significantly this year. Despite expectations of a large operating loss again this year, the company's corporate value is rising on the back of strong ...
WOBURN, Mass., May 3, 2024 /PRNewswire/ -- Curiox Biosystems Co. Ltd (Curiox), a leader in the innovation of life science research technologies, and Beckman Coulter Life Sciences, a global leader in ...
Curiox Biosystems Signs Master Software License Agreement for Enterprise-Scale Pluto Code Deployment
First master licensing framework for Pluto Code enables a global pharmaceutical organization to expand centrifuge-free automation across its liquid-handling infrastructure without repeated contracting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results